News

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug supply ...
Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in the United States.
Former speed skater Sarah Lindsay, 44, believes injections like Ozempic and Mounjaro are causing users to be malnourished and ...
As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...
While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...
Shares of Lexicon Pharmaceuticals LXRX have jumped 30% after signing a licensing deal for its pre-clinical obesity drug ...
The mother of two is aging in reverse, looking like a younger version of herself. After sparking Ozempic rumours, Trainor has finally opened up on the components of her secret weight loss recipe ...
White privilege.” After Handler told her friend that she was “on semaglutide,” her pal confirmed that was the generic version of Ozempic. The comedian later admitted that she was no longer ...
The study evaluated the once-weekly injectable Ozempic (semaglutide 1.0 mg) in adults with type 2 diabetes and PAD, at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo.
Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...
Ozempic (semaglutide) and Wegovy (semaglutide) are brand-name injections. Ozempic is approved for type 2 diabetes, but doctors may sometimes prescribe it off-label for weight loss and management.